ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 137 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18 | -48.6% | 4,009 | -26.6% | 0.00% | – |
| Q2 2023 | $35 | -58.8% | 5,462 | -51.9% | 0.00% | – |
| Q1 2023 | $85 | -91.6% | 11,347 | -88.7% | 0.00% | -100.0% |
| Q4 2022 | $1,017 | -99.8% | 100,491 | +65.3% | 0.00% | 0.0% |
| Q3 2022 | $601,000 | +128.5% | 60,786 | +145.3% | 0.00% | – |
| Q2 2022 | $263,000 | -47.0% | 24,782 | -51.4% | 0.00% | – |
| Q1 2022 | $496,000 | -59.4% | 50,956 | -40.3% | 0.00% | -100.0% |
| Q4 2021 | $1,221,000 | +110.2% | 85,424 | +202.0% | 0.00% | 0.0% |
| Q3 2021 | $581,000 | -3.3% | 28,282 | +3.5% | 0.00% | 0.0% |
| Q2 2021 | $601,000 | +461.7% | 27,322 | +761.9% | 0.00% | – |
| Q1 2021 | $107,000 | – | 3,170 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |